Deininger, M H <br/><br/>
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.  [electronic resource] 

 -  Journal of neuro-oncology  Jun 2000 
 - 121-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0167-594X 
<br/><br/><label>Standard No.: </label>10.1023/a:1006462618800  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>Biomarkers<br/>Brain Neoplasms--drug therapy<br/>Cell Division--drug effects<br/>Chemotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Cranial Irradiation<br/>Cyclophosphamide--analogs & derivatives<br/>Cytarabine--administration & dosage<br/>Disease Progression<br/>Female<br/>GTP-Binding Proteins--biosynthesis<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes--drug effects<br/>Genes, bcl-2--drug effects<br/>Glioblastoma--drug therapy<br/>Humans<br/>Ki-67 Antigen--biosynthesis<br/>Life Tables<br/>Lomustine--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplastic Stem Cells--drug effects<br/>Nimustine--administration & dosage<br/>Protein Glutamine gamma Glutamyltransferase 2<br/>Proto-Oncogene Proteins c-bcl-2--biosynthesis<br/>Radiotherapy, Adjuvant<br/>Survival Analysis<br/>Teniposide--administration & dosage<br/>Transglutaminases--biosynthesis<br/>Tumor Suppressor Protein p53--biosynthesis